GB0912906D0 - Treatment of diabetes and metabolic syndrome - Google Patents
Treatment of diabetes and metabolic syndromeInfo
- Publication number
- GB0912906D0 GB0912906D0 GB0912906A GB0912906A GB0912906D0 GB 0912906 D0 GB0912906 D0 GB 0912906D0 GB 0912906 A GB0912906 A GB 0912906A GB 0912906 A GB0912906 A GB 0912906A GB 0912906 D0 GB0912906 D0 GB 0912906D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- diabetes
- treatment
- metabolic syndrome
- metabolic
- syndrome
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 208000001145 Metabolic Syndrome Diseases 0.000 title 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 title 1
- 206010012601 diabetes mellitus Diseases 0.000 title 1
Priority Applications (15)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0912906A GB0912906D0 (en) | 2009-07-24 | 2009-07-24 | Treatment of diabetes and metabolic syndrome |
| MX2011009559A MX2011009559A (en) | 2009-03-12 | 2010-03-10 | Treatment of diabetes and metabolic syndrome. |
| EP14159411.9A EP2762150A1 (en) | 2009-03-12 | 2010-03-10 | Treatment of Diabetes and Metabolic Syndrome |
| RU2011141291/15A RU2537181C2 (en) | 2009-03-12 | 2010-03-10 | Treating diabetes and metabolic syndrome |
| PCT/EP2010/053044 WO2010103045A1 (en) | 2009-03-12 | 2010-03-10 | Treatment of diabetes and metabolic syndrome |
| AU2010223329A AU2010223329B2 (en) | 2009-03-12 | 2010-03-10 | Treatment of diabetes and metabolic syndrome |
| EP10708193.7A EP2405934B1 (en) | 2009-03-12 | 2010-03-10 | Treatment of diabetes and metabolic syndrome |
| BRPI1009392A BRPI1009392A2 (en) | 2009-03-12 | 2010-03-10 | "pharmaceutical formulation, and use of a pharmaceutically effective amount of a pharmaceutical formulation." |
| CN201080011177.1A CN102369018B (en) | 2009-03-12 | 2010-03-10 | Treatment of diabetes and metabolic syndrome |
| US13/255,854 US20120046224A1 (en) | 2009-03-12 | 2010-03-10 | Treatment of diabetes and metabolic syndrome |
| JP2011553445A JP5993147B2 (en) | 2009-03-12 | 2010-03-10 | Treatment of diabetes and metabolic syndrome |
| KR1020117023810A KR101673042B1 (en) | 2009-03-12 | 2010-03-10 | Treatment of diabetes and metabolic syndrome |
| NZ595021A NZ595021A (en) | 2009-03-12 | 2010-03-10 | Treatment of diabetes and metabolic syndrome with enteral formulations of calcitonin peptides or calcitonin receptor agonists |
| CA2755068A CA2755068C (en) | 2009-03-12 | 2010-03-10 | Treatment of diabetes and metabolic syndrome |
| CL2011002229A CL2011002229A1 (en) | 2009-03-12 | 2011-09-09 | Pharmaceutical formulation comprising an active compound that is a member of the calcitonin family that is not amylin. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0912906A GB0912906D0 (en) | 2009-07-24 | 2009-07-24 | Treatment of diabetes and metabolic syndrome |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB0912906D0 true GB0912906D0 (en) | 2009-08-26 |
Family
ID=41058501
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB0912906A Ceased GB0912906D0 (en) | 2009-03-12 | 2009-07-24 | Treatment of diabetes and metabolic syndrome |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB0912906D0 (en) |
-
2009
- 2009-07-24 GB GB0912906A patent/GB0912906D0/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL259475A (en) | Combination therapy for the treatment of diabetes | |
| IL210856A0 (en) | Combination therapy for the treatment of diabetes and related conditions | |
| PL3181134T3 (en) | Bifidobacteria for treating diabetes and related conditions | |
| EP2376077A4 (en) | Composition and method for treatment of diabetes | |
| GB2552405B (en) | A combination pharmaceutical composition and methods of treating diabetes and metabolic disorders | |
| ZA201300055B (en) | Treatment of gout and hyperuricemia | |
| IL223289A0 (en) | Treatment of type 2 diabetes | |
| IL219055A0 (en) | Medical devices and pumps therefor | |
| EP2480246A4 (en) | Composition and method for treatment of diabetes | |
| IL217966A0 (en) | Hsl inhibitors useful in the treatment of diabetes | |
| ZA201304353B (en) | Remedial composition and treatment methods | |
| PT2575858T (en) | Methods for treatment of nephrotic syndrome and related conditions | |
| PL2397151T3 (en) | Treatment of vascular complications of diabetes | |
| EP2498810A4 (en) | Treatment of sleep disordered breathing with neurotoxin | |
| ZA201404738B (en) | Treatment of type i and type ii diabetes | |
| EP2498794A4 (en) | Method of treatment of type 2 diabetes | |
| GB0904271D0 (en) | Treatment of diabetes and metabolic syndrome | |
| GB0910904D0 (en) | Treatment of diabetes and metabolic syndrome | |
| GB0912906D0 (en) | Treatment of diabetes and metabolic syndrome | |
| GB201003894D0 (en) | Inhibitors of glucose metabolism for use in the treatment of Birt-Hogg-Dubé syndrome | |
| GB0802904D0 (en) | Treatment of metabolic syndrome | |
| GB0802903D0 (en) | Treatment of diabetes | |
| AU2009900265A0 (en) | Treatment of diabetes and other diseases | |
| AU2010902914A0 (en) | Treatment of diabetes | |
| GB201007977D0 (en) | Treatment of cardiovascular disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |